INNOVADERM CRO IS NOW INDERO.

Building Momentum in Clinical Trial Start‑Up

Esther Sanchez

Esther Sanchez

Associate Director, Start-Up

Author picture

Delays in site start‑up remain one of the biggest obstacles to efficient clinical trial delivery, often caused by lengthy feasibility processes, protracted contract negotiations and poor communication between stakeholders. This International Clinical Trials article, written by Esther Sanchez, Associate Director, Start-Up at Indero, highlights practical insights on how to overcome these challenges through data‑driven site selection, operational alignment and clear communication.

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

Fields marked with * are required.